Epiminder (ASX:EPI)
ASX announcement history & article coverage
Transparent by design.
Announcments by Epiminder (ASX:EPI) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
100th patient enrolled in US study ahead of schedule
Epiminder enrolls 100th DETECT study participant ahead of schedule
Updated Securities Trading Policy
Change of Director's Interest Notice DO
Notice of Annual General Meeting/Proxy Form
75th DETECT Enrollee
Epiminder reaches 75-patient enrolment milestone in US DETECT study
Change of Director's Interest Notice PB
Change of Director's Interest Notice DO
FY26 Appendix 4G and Corporate Governance Statement
FY26 Appendix 4E and Annual Report
Epiminder reports AUD 42.7m loss, advances FDA-approved epilepsy monitor commercialization post $125m IPO
Change of Director's Interest Notice JS
Change of Director's Interest Notice DO
Change of Director's Interest Notice RK
FY26 Investor Presentation
Epiminder advances FDA-cleared Minder System with strong clinical progress and funding to support US commercial launch in 2028
Quarterly Activities/Appendix 4C Cash Flow Report
Epiminder reports strong FY26 progress with IPO funds, patient enrolments, Medicare reimbursement boost, and next-gen device development on track
